A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Boehringer Ingelheim
National Cancer Institute (NCI)
AbbVie
Travera Inc
Eli Lilly and Company
Jazz Pharmaceuticals
Seagen Inc.
Pfizer
AstraZeneca
Eli Lilly and Company
Hoffmann-La Roche
UMC Utrecht
ViroMissile, Inc.
Erasca, Inc.
Sichuan Enray Pharmaceutical Sciences Company
Duke University
Arvinas Inc.
Tasca Therapeutics
Dana-Farber Cancer Institute
Poseida Therapeutics, Inc.
MacroGenics
Boehringer Ingelheim
City of Hope Medical Center
xCures
Daiichi Sankyo
SN BioScience
University of Nebraska
Takeda
Zhejiang University
Adela, Inc
Natera, Inc.
Second Life Therapeutics
Var2 Pharmaceuticals
VM Oncology, LLC
Degron Therapeutics Co.
Cancer Research UK
University of Southern California
Tempus AI
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Maastricht University Medical Center
Day One Biopharmaceuticals, Inc.
LigaChem Biosciences, Inc.
Ikena Oncology
GI Innovation, Inc.
Memgen, Inc.
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.